Theravance Biopharma Inc (NASDAQ: TBPH) — Healthcare · Share Price, Chart & Market Data
About: Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $16.86 (+2.40%)
TBPHTheravance Biopharma Inc
Loading watchlist status…
Trade TBPH now
Theravance Biopharma Inc share price
TBPH price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 4:24 pm GMT+0
TBPH price performance
1.414%
5D
11.771%
1M
-7.135%
YTD
72.872%
1Y
TBPH price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 4:24 pm GMT+0
TBPH details
TBPH Market Signals